| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 04/30/2002 | US6380154 Synthetic proteins for in vivo drug delivery and tissue augmentation |
| 04/30/2002 | US6379945 Gene switch |
| 04/30/2002 | US6379924 Amplifying protein products by using fungal cells having a plasmid with a funcional coding sequence and also having a modified level of ubiquitin conjugating enzymes activity; then culturing the cell to produce a fungal derived product |
| 04/30/2002 | US6379907 Detecting cancerous cervical lesions from atypical glandular cells of undetermined significance papanicolaou smear cells based on the presence of a specific antigen not found in atypical cells, but present on normal endocervical cells |
| 04/30/2002 | US6379903 Purification of recombinant proteins fused to multiple epitopes |
| 04/30/2002 | US6379902 Mycrobacterial proteins, microorganisms producing same and uses of said proteins in vaccines and for detecting tuberculosis |
| 04/30/2002 | US6379901 Detecting cancer cells that express a human leukocyte antigen molecule using a nonapeptide derived from the tumor rejection antigen precursor; mixing cells and nonapeptide to form complexes; expose to cytolytic cells and determine lysis |
| 04/30/2002 | US6379887 A polynucleotide; used in cosmetic and dermatology development |
| 04/30/2002 | US6379678 Culture product; antiallergens |
| 04/30/2002 | US6379675 Immunological combination compositions and methods |
| 04/30/2002 | US6379671 Using a polypeptide antigen mixture |
| 04/30/2002 | US6379668 Therapy for autoimmune disease |
| 04/30/2002 | US6379662 Human interleukin variation |
| 04/30/2002 | CA2151045C Platelet-activating factor acetylhydrolase |
| 04/30/2002 | CA2071908C Antibody antagonists of human interleukin-4 |
| 04/30/2002 | CA2064689C Stabilized protein or peptide conjugates |
| 04/30/2002 | CA2047997C Antibiotic, balhimycin, a process for its production and its use as pharmaceutical |
| 04/30/2002 | CA2020247C Antibodies reactive with human carcinomas |
| 04/27/2002 | CA2360015A1 Angiotensin i-converting enzyme inhibitory substance |
| 04/25/2002 | WO2002033122A1 Method of examining allergic diseases |
| 04/25/2002 | WO2002033099A2 Human kinases |
| 04/25/2002 | WO2002033092A1 Gene sp17 inhibiting lesion formation in plant and utilization thereof |
| 04/25/2002 | WO2002033086A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 04/25/2002 | WO2002033079A2 Human g-protein coupled receptor and uses thereof |
| 04/25/2002 | WO2002033074A1 Artificial protein having potentiated immunogenicity of epitope |
| 04/25/2002 | WO2002033069A1 Method of examining allergic disease |
| 04/25/2002 | WO2002033065A2 Method for producing proteins by electroporation |
| 04/25/2002 | WO2002033049A1 Human tuberoinfundibular peptide of 39 residues |
| 04/25/2002 | WO2002032961A2 Novel polypeptides and nucleic acids encoding same |
| 04/25/2002 | WO2002032958A2 Polynucleotide and polypeptide sequences of human dendritic cell immunoreceptors |
| 04/25/2002 | WO2002032953A2 Pregnancy-associated plasma protein-a2 (papp-a2) |
| 04/25/2002 | WO2002032943A2 Modifications of hiv env, gag, and pol enhance immunogenicity for genetic immunization |
| 04/25/2002 | WO2002032937A2 Neuromedin u delta |
| 04/25/2002 | WO2001098506A3 Methods and means for regulation of gene expression |
| 04/25/2002 | WO2001096400A3 52871, a novel human g protein coupled receptor and uses thereof |
| 04/25/2002 | WO2001093805A3 FUSION OF jAZF1 AND jjAZ1 GENES IN ENDOMETIRIAL STROMAL TUMORS |
| 04/25/2002 | WO2001088136A3 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 04/25/2002 | WO2001061010A3 GTPASE activating proteins |
| 04/25/2002 | WO2001060975A3 Gene disruption methodologies in fungi for drug target discovery |
| 04/25/2002 | WO2001042471A3 Polypeptides and polynucleotides encoding same |
| 04/25/2002 | US20020048816 Genetically engineered cell; for use as a vaccine; for use in screening polypeptides and antigens; for use as a support for immobilizing an enzyme, peptide or antigen |
| 04/25/2002 | US20020048794 Polypeptides for use in the diagnosis and treatment of skin disorders, cancer, vision and demyelination defects, inflammation, glomerculonephritis, Kaposi's sarcoma, angiogenesis, sarcoidosis, osteoarthritis and aneurysm |
| 04/25/2002 | US20020048791 Nucleotide sequences coding preferential polypeptides; for use in the treatment of dietetics, diabetes, anxiety, hypertension, drug dependence, congestive heart failure, cardiovascular disorders, tumors and nervous system disorders |
| 04/25/2002 | US20020048790 Nucleotide sequences coding binding protein for use in the prevention of infections; bactericides |
| 04/25/2002 | US20020048786 Nucleotide sequences for use in the treatment of infections, arthritis, karposi's sarcoma, allergies, asthma, nervous system and autoimmune diseases |
| 04/25/2002 | US20020048783 Immunoglobulin for use in the detection of preferential proteins in bodily fuids of mammals |
| 04/25/2002 | US20020048769 Protein-protein interactions in neurodegenerative disorders |
| 04/25/2002 | US20020048583 Combining ex vivo an antigen and an antigen-presenting cell binding agent specific for the antigen, and administering the composition to a patient suffering from a disease associated with the antigen |
| 04/25/2002 | US20020048578 Modified version of a therapeutic antibody with affinity for a cell-surface antigen; capable of inducing immunological tolerance to the therapeutic antibody |
| 04/25/2002 | US20020048562 Tolerogenic fusion proteins of immunoglobulins and methods for inducing and maintaining tolerance |
| 04/25/2002 | DE10050091A1 New casein-derived peptide with growth promoting activity, useful as additive for eukaryotic cell cultures and for recombinant protein production |
| 04/25/2002 | DE10049673A1 Enzymatic synthesis of peptide, its mimic or protein, useful e.g. in drug development, using a modified ligase adapted to a particular ester leaving group |
| 04/25/2002 | CA2818654A1 Pregnancy-associated plasma protein-a2 (papp-a2) |
| 04/25/2002 | CA2464121A1 Pregnancy-associated plasma protein-a2 (papp-a2) |
| 04/25/2002 | CA2426698A1 Method for producing proteins by electroporation |
| 04/25/2002 | CA2426371A1 Human tuberoinfundibular peptide of 39 residues |
| 04/25/2002 | CA2425963A1 Human kinases |
| 04/25/2002 | CA2425763A1 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 04/25/2002 | CA2425723A1 Neuromedin u delta |
| 04/24/2002 | EP1199362A2 Immunoregulator from the family designated 'leukocyte immunoglobulin-like receptors' (LIR) |
| 04/24/2002 | EP1199361A2 Glycoprotein hormone receptor molecules. Their uses |
| 04/24/2002 | EP1199360A2 Active and inactive CC-chemokine receptors and nucleic acid molecules encoding said receptor |
| 04/24/2002 | EP1199359A1 Human metabotropic glutamate receptor subtypes (HMR4, HMR6, HMR7) and related DNA compounds |
| 04/24/2002 | EP1199080A2 Co-administration of interleukin-3 mutants with colony stimulating factors |
| 04/24/2002 | EP1198581A1 Structural protein of adeno-associated virus with modified antigenicity, its production and its use |
| 04/24/2002 | EP1198580A1 Scleroprotein of an adeno-associated virus with modified chromatographic properties, the production thereof and use of the same |
| 04/24/2002 | EP1198569A1 G-protein coupled receptor and dna sequences thereof |
| 04/24/2002 | EP1198568A1 Compositions and methods for the treatment of immune related diseases |
| 04/24/2002 | EP1198563A2 Novel fibroblast growth factor and nucleic acids encoding same |
| 04/24/2002 | EP1198480A2 Hybridomas for lung cancer marker and monoclonal antibodies thereof |
| 04/24/2002 | EP1198471A1 Process for deacylation of lipodepsipeptides |
| 04/24/2002 | EP1198468A1 Stabilized viral envelope proteins and uses thereof |
| 04/24/2002 | EP1198238A2 Gene encoding nade, p75ntr -associated cell death executor and uses thereof |
| 04/24/2002 | EP1137812A4 Dna-protein fusions and uses thereof |
| 04/24/2002 | EP0797452B1 Modulating the immune response |
| 04/24/2002 | EP0752008B1 Dna mutagenesis by random fragmentation and reassembly |
| 04/24/2002 | CN1346407A Production of pancreatic procarboxy-peptidease B, isoforms and nuteins thereof, and their use |
| 04/24/2002 | CN1346406A Human ubiquitin ligase E3 for the modulation of NF-kappa 8 |
| 04/24/2002 | CN1346372A Anti-idiotypic antibodies against antibodies which inhibit the binding of immunoglobuline to its high affinity receptor |
| 04/24/2002 | CN1346371A Monoclonal antibodies, antigens and diagnosis and therapy of malignant diseases |
| 04/24/2002 | CN1346370A Polypeptides involved in immune response |
| 04/24/2002 | CN1346368A Potassium channel interactors and uses therefor |
| 04/24/2002 | CN1345930A Novel polyepptide-human lipase 29.59 and polynucleotide for encoding said polypeptide |
| 04/24/2002 | CN1345798A Novel human Cdc2 related protein kinase, its coding sequence and use |
| 04/24/2002 | CN1345545A Method for recovering soybean protein extract richly-containing isoflavone aglycone |
| 04/24/2002 | CN1083488C Method for production of recombining human grunlocyte colony stimulation factor |
| 04/24/2002 | CN1083487C Cyclodextrin glycosyl transferases for producing game-cyclodextrin |
| 04/24/2002 | CA2359606A1 Cysteine/glycine rich peptides |
| 04/23/2002 | US6376752 Cytoplasmic inhibition of gene expression in a plant |
| 04/23/2002 | US6376660 Human N-methyl-D-aspartate receptor subunits, nucleic acids encoding same and uses therefor |
| 04/23/2002 | US6376659 Recombinant expression vector |
| 04/23/2002 | US6376654 Myeloma cell and ovarian cancer cell surface glycoproteins, antibodies thereto, and uses thereof |
| 04/23/2002 | US6376653 Tie2 antagonist antibodies |
| 04/23/2002 | US6376651 Amino acid sequences of a caf 1-related protein and to the use of these sequences in the diagnosis, treatment, and prevention of disorders associated with cell proliferation and inflammation. |
| 04/23/2002 | US6376473 Polynucleotide vaccine formula in particular against bovine respiratory pathology |
| 04/23/2002 | US6376464 That form amphipathic helices, bind lipids, form prebeta-like or hdl-like complexes, activate lcat, increase serum levels of hdl fractions, and promote cholesterol efflux, dyslipopro-teinemia, hypercholesterolemia, cardiovascular disorders |
| 04/23/2002 | US6376463 Modified factor VIII |
| 04/23/2002 | US6376459 Specific for gp39 on t cells was able to inhibit helper t-cell mediated b-cell activation by binding to a novel 39 kd protein receptor on helper t-cell membranes |
| 04/23/2002 | US6376253 Cultivation of a microbial culture containing isotopically labeled amino acids |
| 04/23/2002 | US6376248 Peptide-enhanced transfections |